Table 2

ARRIVE Vein Graft Stenting Procedural Characteristics

VariableARRIVE Vein Graft Stenting (474 Patients; 524 Vessels; 578 Lesions)
Clinical procedural success95.3% (462)
Technical success99.0% (483)
Implant success94.4% (458)
Pre-dilation48.3% (279)
Recipient vessel for graft§
 LAD/diagonal26.3% (152/578)
 Circumflex/OM38.1% (220/578)
 RCA/PDA35.5% (205/578)
Vessels treated/patient
 189.7% (425)
 210.1% (48)
 ≥30.2% (1)
Lesions treated/patient
 181.0% (384)
 216.5% (78)
 ≥32.5% (12)
Stents/vessel1.4 ± 0.7 (522) (1.0, 6.0)
Stents/lesion1.2 ± 0.6 (576) (1.0, 6.0)
Total stent length/lesion (mm)24.0 ± 16.7 (576) (8.0, 180.0)
Stents/patient1.5 ± 0.9 (473) (1.0, 7.0)
 167.1% (318)
 221.9% (104)
 ≥310.8% (51)
Stent length/patient (mm)29.3 ± 21.0 (473) (8.0, 180.0)
Embolic protection device28.9% (137)
Pre-stenting TIMI flow grade (per lesion)
 03.1% (18)
 13.5% (20)
 219.7% (114)
 373.7% (426)
Post-stenting TIMI flow grade (per lesion)
 00.2% (1)
 10.0% (0)
 21.2% (7)
 398.6% (569)
Post-dilation (per lesion)37.9% (219)
Post-stent balloon pressure (atm)15.9 ± 4.0 (218) (3.0, 25.0)
Slow flow/no flow after PCI6.6% (38)
Post-procedure %DS1.3 ± 6.6 (576) (0.0, 100.0)
Procedural medications
 sGPIIb/IIIa inhibitor44.3% (210)
 Bivalirudin37.3% (177)
 Aspirin71.3% (338)
 Clopidogrel81.0% (384)
 DAPT67.7% (321)

Data are presented as % (n) or mean ± SD (n) (minimum, maximum).

DAPT = dual antiplatelet therapy (aspirin plus clopidogrel/ticlopidine); DS = diameter stenosis; LAD = left anterior descending artery; OM = obtuse marginal; PDA = posterior descending artery; RCA = right coronary artery; other abbreviations as in Table 1.

  • Clinical procedural success was defined as mean lesion diameter stenosis <30%, a Thrombolysis In Myocardial Infarction (TIMI) flow grade of 3 as visually assessed by the physician, and no in-hospital clinical events committee-adjudicated events (n = 485).

  • Technical success was defined as a successful delivery or deployment of the study stent to the target lesion without device malfunction (n = 488).

  • Implant success was defined as the percentage of implant procedures exhibiting both procedural and technical success (n = 485).

  • § Left main in 1 patient (0.2%).

  • 1 patient received ticlopidine (0.2%).